# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
For the full year 2024 revenues to be approximately flat versus 2023. Company sees second half growth versus both first half of...
Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. This ...
Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of Adj $0.04 per share which missed the analyst consensus estimate...
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...
Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that it will be showcasing its latest product innovations at the Society...